To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene SLC35B3TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
310 supporting clones for gene SLC35B3 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DB453333 testis .a 1 to 453 1 to 454   tiling clone,   454/455
(99 %)
5 diff
(99.0 %id)
BP342288 stomach mucosa .a 30 to 610 1 to 581       581/583
(99 %)
3 diff
(99.5 %id)
BP203323 coronary artery .a 31 to 542 1 to 512       512/522
(98 %)
4 diff
(99.3 %id)
CR626516 neuroblastoma .a 191 to 1380 1 to 1190   tiling clone,   1190/1190
(100 %)
0 diff
(100 %id)
AL516484 brain, neuroblastoma, neuroblastoma cells .a 191 to 728 1 to 538   fully sequenced,   538/538
(100 %)
0 diff
(100 %id)
BU941358 mixed (pool of 40 RNAs) .a 470 to 1271 1 to 819       817/872
(93 %)
25 diff
(97.2 %id)
AL516483 brain, neuroblastoma, neuroblastoma cells .a 667 to 1368 715 to 15   fully sequenced,   701/715
(98 %)
7 diff
(99.1 %id)
AA357193   .a 1061 to 1443 383 to 1   tiling clone,   383/383
(100 %)
2 diff
(99.5 %id)
NM_001142540.1   .b 1 to 2062 1 to 2062 exact RefSeq, AAA   2062/2062
(100 %)
0 diff
(100 %id)
BG397751 B-cells, primary B-cells from tonsils (cell line) .b 50 to 317 1 to 269   tiling clone,   269/269
(100 %)
3 diff
(98.9 %id)
NM_015948.3   .c 1 to 2213 1 to 2213 exact RefSeq, AAA   2213/2213
(100 %)
0 diff
(100 %id)
DC368779   .c 47 to 586 1 to 541   tiling clone,   541/541
(100 %)
1 diff
(99.9 %id)
CN346196 embryonic stem cells, cell lines H1, H7, andH9 .c 55 to 356 1 to 302       302/302
(100 %)
5 diff
(98.4 %id)
BC006973 Kidney, hypernephroma .c 170 to 2209 1 to 2041 exact tiling clone, available from MGC, AAA   2041/2041
(100 %)
4 diff
(99.9 %id)
BF031801 hypernephroma, Kidney .c 190 to 782 1 to 590       590/843
(69 %)
12 diff
(98.6 %id)
AA995621 2 pooled tumors (clear cell type), Kidney .c 196 to 361 315 to 150   tiling clone, AAA   166/298
(55 %)
0 diff
(100 %id)
DB188586 liver, tumor tissue .d 1 to 563 2 to 564   tiling clone, capped   563/563
(100 %)
0 diff
(100 %id)
NM_001142541.1   .d 6 to 1856 1 to 1851 exact RefSeq, AAA   1851/1851
(100 %)
0 diff
(100 %id)
AK313522   .d 22 to 1377 1 to 1356 V62A     1356/1356
(100 %)
2 diff
(99.9 %id)
DA699273   .d 23 to 548 2 to 527   capped   526/526
(100 %)
1 diff
(99.9 %id)
DB049565 testis .d 23 to 597 2 to 577   capped   576/576
(100 %)
3 diff
(99.5 %id)
DA036915 breast .d 50 to 636 2 to 588   capped   587/587
(100 %)
0 diff
(100 %id)
CR605449 Neuroblastoma Cot 50-normalized .d 127 to 1836 1 to 1664 D2Y L3V T4W Q5S Q6G ...     1664/1664
(100 %)
0 diff
(100 %id)
AL530702 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .d 127 to 918 1 to 745   fully sequenced,   745/745
(100 %)
6 diff
(99.2 %id)
AF132953   .d 142 to 1417 1 to 1273 N367M V368F Y369T S370A N372I ...     1273/1273
(100 %)
12 diff
(99.1 %id)
C03105 heart .d 142 to 454 1 to 316       316/316
(100 %)
7 diff
(97.8 %id)
AA229477   .d 143 to 493 1 to 351       351/351
(100 %)
0 diff
(100 %id)
AB231931 colon .d 163 to 1377 1 to 1215 exact tiling clone,   1215/1215
(100 %)
0 diff
(100 %id)
TI_1948126141   .d 168 to 884 135 to 851   fully sequenced,   717/851
(84 %)
0 diff
(100 %id)
TI_1948126287   .d 168 to 793 124 to 749   fully sequenced,   626/749
(83 %)
3 diff
(99.6 %id)
TI_1948126446   .d 168 to 884 129 to 845   fully sequenced,   717/845
(84 %)
0 diff
(100 %id)
TI_1948126589   .d 168 to 815 130 to 777   fully sequenced,   648/777
(83 %)
0 diff
(100 %id)
CV027272 mixed .d 172 to 823 1 to 652       652/652
(100 %)
0 diff
(100 %id)
BX352936 Neuroblastoma Cot 10-normalized .d 175 to 842 48 to 712       666/723
(92 %)
21 diff
(97.1 %id)
BX480900   .d 192 to 490 1 to 299       299/299
(100 %)
0 diff
(100 %id)
CD108707 brain, Pituitary .d 204 to 1043 1 to 846       846/874
(96 %)
12 diff
(98.7 %id)
DB188942 liver, tumor tissue .d 207 to 783 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
AA075033   .d 223 to 654 1 to 436       436/436
(100 %)
4 diff
(99.1 %id)
FN049428 breast carcinoma .d 225 to 295 71 to 1     Submitted on the opposite strand 71/71
(100 %)
0 diff
(100 %id)
DA568531 whole embryo, mainly head .d 230 to 970 2 to 741   capped   740/752
(98 %)
4 diff
(99.5 %id)
AA357194   .d 357 to 758 1 to 400       400/400
(100 %)
9 diff
(97.8 %id)
BU169995 epithelioid carcinoma, Pancreas .d 452 to 1331 1 to 890       890/891
(99 %)
15 diff
(98.4 %id)
BG743034 skin .d 462 to 1238 4 to 771       768/772
(99 %)
19 diff
(97.6 %id)
CB162346 Liver .d 465 to 801 74 to 410       340/410
(82 %)
12 diff
(97.1 %id)
CD242731 brain, Pituitary .d 467 to 935 1 to 471       471/1455
(32 %)
7 diff
(99.6 %id)
BU168189 epithelioid carcinoma, Pancreas .d 478 to 1048 72 to 648       577/1043
(55 %)
18 diff
(98.3 %id)
AA228721   .d 486 to 844 359 to 1       359/359
(100 %)
0 diff
(100 %id)
FN135411 breast carcinoma .d 540 to 654 1 to 115       115/115
(100 %)
0 diff
(100 %id)
BG778226 adenocarcinoma, Prostate .d 619 to 1314 1 to 696       696/696
(100 %)
6 diff
(99.2 %id)
TI_154047928   .d 737 to 1613 953 to 86   AAA   868/1003
(86 %)
20 diff
(98.1 %id)
BX362357   .d 753 to 1558 833 to 21       812/841
(96 %)
35 diff
(95.9 %id)
TI_1948126288   .d 763 to 1380 721 to 99   fully sequenced,   621/719
(86 %)
8 diff
(98.9 %id)
TI_1948126590   .d 785 to 1380 714 to 119   fully sequenced,   596/714
(83 %)
0 diff
(100 %id)
TI_1948126142   .d 823 to 1380 678 to 121   fully sequenced,   558/678
(82 %)
0 diff
(100 %id)
TI_1948126447   .d 823 to 1380 676 to 119   fully sequenced,   558/676
(82 %)
0 diff
(100 %id)
AL530701 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .d 888 to 1836 949 to 1   fully sequenced,   952/952
(100 %)
32 diff
(96.7 %id)
AV725475 hypothalamus .d 950 to 1301 14 to 381       384/381
(100 %)
59 diff
(84.6 %id)
AA091429   .d 964 to 1173 1 to 212       212/212
(100 %)
7 diff
(96.7 %id)
BF749720 breast_normal .d 971 to 1450 487 to 8     Submitted on the opposite strand 480/487
(98 %)
1 diff
(99.8 %id)
BM979248 lung, Primary Lung Epithelial Cells .d 971 to 1622 670 to 19   AAA   652/652
(100 %)
1 diff
(99.9 %id)
TI_151798337   .d 1012 to 1628 155 to 774       620/775
(80 %)
10 diff
(98.8 %id)
DR423172 eye, Pterygium .d 1025 to 1737 1 to 713       713/713
(100 %)
0 diff
(100 %id)
TI_154049393   .d 1040 to 1852 896 to 91   AAA   806/964
(83 %)
15 diff
(98.5 %id)
TI_154117651   .d 1046 to 1853 898 to 94   AAA   805/936
(86 %)
4 diff
(99.6 %id)
AV659500 corresponding non cancerous liver tissue .d 1074 to 1454 1 to 381     Submitted on the opposite strand 381/383
(99 %)
1 diff
(99.8 %id)
W38714 parathyroid gland, parathyroid tumor .d 1082 to 1314 1 to 237       237/237
(100 %)
5 diff
(97.9 %id)
CA390950 eye, RPE/choroid .d 1124 to 1685 1 to 562       562/562
(100 %)
1 diff
(99.9 %id)
BQ773203 Chondrosarcoma Cell line .d 1124 to 1852 747 to 19   AAA   729/731
(99 %)
0 diff
(100 %id)
BX331488 Neuroblastoma Cot 10-normalized .d 1142 to 1819 704 to 11       535/882
(60 %)
22 diff
(97.6 %id)
TI_154127923   .d 1152 to 1852 781 to 82   AAA   700/896
(78 %)
22 diff
(97.6 %id)
BM996988 Chondrosarcoma, Left Pubic Bone .d 1153 to 1852 718 to 19   AAA   700/700
(100 %)
1 diff
(99.9 %id)
BQ014329 Chondrosarcoma, Left Pubic Bone .d 1165 to 1853 707 to 19   AAA   689/689
(100 %)
1 diff
(99.9 %id)
CA440037 lung, Metastatic Chondrosarcoma .d 1178 to 1856 697 to 19   AAA   679/679
(100 %)
1 diff
(99.9 %id)
AW936129 denis_drash .d 1187 to 1721 1 to 535       535/535
(100 %)
4 diff
(99.3 %id)
BQ010840 placenta .d 1187 to 1856 687 to 19   AAA   669/669
(100 %)
3 diff
(99.6 %id)
AW605142 denis_drash .d 1188 to 1716 530 to 1       530/530
(100 %)
5 diff
(99.1 %id)
CA449792 Chondrosarcoma, Left Pelvis .d 1193 to 1853 679 to 19   AAA   661/661
(100 %)
0 diff
(100 %id)
AW605144 denis_drash .d 1194 to 1724 540 to 9       532/540
(98 %)
0 diff
(100 %id)
CA413498 Chondrosarcoma Grade II, Left Pelvis .d 1212 to 1852 659 to 19   AAA   641/641
(100 %)
0 diff
(100 %id)
BX095167 lung .d 1238 to 1856 633 to 15   AAA   619/619
(100 %)
0 diff
(100 %id)
W07150 lung .d 1267 to 1846 593 to 12     Submitted on the opposite strand 582/599
(97 %)
0 diff
(100 %id)
BQ774560 Chondrosarcoma Grade II, Left Pelvis .d 1271 to 1856 604 to 19   AAA   586/586
(100 %)
0 diff
(100 %id)
DB355044 whole embryo, mainly head .d 1275 to 1856 579 to 1       579/580
(99 %)
11 diff
(98.2 %id)
AA169452   .d 1278 to 1762 488 to 1     Submitted on the opposite strand 488/496
(98 %)
13 diff
(97.4 %id)
CR738071 pooled .d 1283 to 1678 1 to 396       396/396
(100 %)
0 diff
(100 %id)
CR738124 colon .d 1283 to 1664 1 to 382       382/382
(100 %)
0 diff
(100 %id)
AW975096   .d 1307 to 1852 112 to 657   AAA   546/657
(83 %)
6 diff
(99.1 %id)
AW197692 Kidney .d 1313 to 1857 545 to 1       545/545
(100 %)
1 diff
(99.9 %id)
AI680140 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .d 1341 to 1856 516 to 1       516/516
(100 %)
0 diff
(100 %id)
AI953586 Kidney .d 1341 to 1856 516 to 1       516/516
(100 %)
0 diff
(100 %id)
AW471313 adenocarcinoma, Pancreas .d 1341 to 1852 512 to 1       512/512
(100 %)
0 diff
(100 %id)
CB048498 Prostate .d 1342 to 1832 28 to 518   fully sequenced,   491/518
(94 %)
6 diff
(98.9 %id)
AA248996   .d 1345 to 1622 1 to 270       270/271
(99 %)
22 diff
(91.9 %id)
AW276216 lung, two pooled squamous cell carcinomas .d 1350 to 1855 507 to 2       506/507
(99 %)
0 diff
(100 %id)
AI420298 Prostate .d 1366 to 1856 491 to 1       491/491
(100 %)
0 diff
(100 %id)
AW054987 adenocarcinoma, Pancreas .d 1366 to 1858 496 to 4   tiling clone,   493/496
(99 %)
0 diff
(100 %id)
N92598 parathyroid gland, parathyroid tumor .d 1374 to 1856 486 to 11   AAA   476/485
(98 %)
8 diff
(98.4 %id)
BQ012121 placenta .d 1376 to 1856 499 to 19   AAA   481/481
(100 %)
0 diff
(100 %id)
CB048497 Prostate .d 1381 to 1854 516 to 44   fully sequenced, AAA   473/473
(100 %)
1 diff
(99.8 %id)
DB576665 hypothalamus .d 1382 to 1859 1 to 478   tiling clone, Submitted on the opposite strand 478/478
(100 %)
0 diff
(100 %id)
AA722673 heart .d 1383 to 1856 473 to 1       473/473
(100 %)
1 diff
(99.8 %id)
AW467500 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .d 1389 to 1852 475 to 13   AAA   463/463
(100 %)
2 diff
(99.6 %id)
CB122474 Liver .d 1392 to 1856 479 to 15   AAA Submitted on the opposite strand 465/465
(100 %)
0 diff
(100 %id)
BE645240 pooled .d 1398 to 1852 460 to 6       455/460
(98 %)
0 diff
(100 %id)
AA779816   .d 1399 to 1848 457 to 8       450/457
(98 %)
0 diff
(100 %id)
AA652231 normal prostate, Prostate .d 1409 to 1733 324 to 1       324/329
(98 %)
0 diff
(100 %id)
AA767728 germinal center B cell .d 1412 to 1856 475 to 32   AAA   444/444
(100 %)
5 diff
(98.9 %id)
AI955631 adenocarcinoma, Pancreas .d 1416 to 1858 443 to 1       443/443
(100 %)
3 diff
(99.4 %id)
AI138958   .d 1418 to 1858 445 to 5       441/445
(99 %)
0 diff
(100 %id)
AW130169 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 1418 to 1857 440 to 1       440/440
(100 %)
0 diff
(100 %id)
AI473986 colon, moderately-differentiated adenocarcinoma .d 1421 to 1856 436 to 1       436/436
(100 %)
2 diff
(99.6 %id)
BE048962 Kidney .d 1421 to 1858 443 to 6       438/443
(98 %)
0 diff
(100 %id)
AA658199   .d 1427 to 1659 1 to 233       233/233
(100 %)
3 diff
(98.8 %id)
AW276204 lung, two pooled squamous cell carcinomas .d 1436 to 1855 420 to 1       420/420
(100 %)
2 diff
(99.6 %id)
AI445162 colon, moderately-differentiated adenocarcinoma .d 1438 to 1852 415 to 1       415/415
(100 %)
0 diff
(100 %id)
AW301242 Kidney .d 1444 to 1856 413 to 1       413/413
(100 %)
2 diff
(99.6 %id)
AW015696   .d 1445 to 1856 429 to 18   AAA   412/412
(100 %)
5 diff
(98.8 %id)
AV729224 hypothalamus .d 1452 to 1856 329 to 734   AAA   406/423
(95 %)
6 diff
(98.6 %id)
AW197776 pooled .d 1461 to 1858 404 to 4       401/404
(99 %)
0 diff
(100 %id)
AA618518 normal prostate, Prostate .d 1462 to 1856 395 to 1       395/395
(100 %)
0 diff
(100 %id)
AA831190 germinal center B cell .d 1463 to 1858 403 to 8       396/403
(98 %)
0 diff
(100 %id)
FN051256 breast carcinoma .d 1464 to 1552 1 to 89       89/89
(100 %)
1 diff
(98.9 %id)
BE676861 B-cell, chronic lymphotic leukemia .d 1468 to 1858 398 to 8       391/398
(98 %)
0 diff
(100 %id)
AI042395 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 1471 to 1853 383 to 1       383/383
(100 %)
3 diff
(99.3 %id)
AI620439 Prostate .d 1471 to 1857 387 to 1       387/387
(100 %)
0 diff
(100 %id)
AI765568 2 pooled tumors (clear cell type), Kidney .d 1476 to 1854 383 to 5       379/383
(98 %)
0 diff
(100 %id)
AI769381 2 pooled tumors (clear cell type), Kidney .d 1476 to 1854 383 to 5       379/383
(98 %)
0 diff
(100 %id)
AI936423 2 pooled tumors (clear cell type), Kidney .d 1476 to 1854 384 to 5       380/384
(98 %)
0 diff
(100 %id)
AW263277 brain, three pooled meningiomas .d 1477 to 1856 383 to 1       383/383
(100 %)
3 diff
(99.3 %id)
BM666270 eye, fetal eyes .d 1493 to 1855 382 to 20   AAA   363/364
(99 %)
0 diff
(100 %id)
AW615082 2 pooled high-grade transitional celltumors, genitourinary tract .d 1494 to 1852 364 to 6       359/364
(98 %)
0 diff
(100 %id)
AW197858 pooled .d 1504 to 1858 359 to 4       356/359
(99 %)
0 diff
(100 %id)
AI245709 Kidney .d 1516 to 1858 343 to 1       343/343
(100 %)
1 diff
(99.8 %id)
AI367225 serous papillary carcinoma, high grade, 2pooled tumors, uterus .d 1516 to 1852 350 to 14   AAA   337/337
(100 %)
4 diff
(98.9 %id)
AA827775 germinal center B cell .d 1552 to 1852 306 to 6       301/306
(98 %)
0 diff
(100 %id)
AA832355 germinal center B cell .d 1576 to 1856 298 to 17   AAA   282/282
(100 %)
2 diff
(99.3 %id)
AA642364 germinal center B cell .d 1588 to 1818 231 to 1       231/231
(100 %)
0 diff
(100 %id)
AA075034   .d 1591 to 1853 270 to 4       267/273
(97 %)
0 diff
(100 %id)
AI302136 carcinoid, lung .d 1597 to 1856 289 to 30   AAA   260/260
(100 %)
5 diff
(98.1 %id)
BE247082 leukopheresis .d 1629 to 1852 227 to 4       224/227
(98 %)
0 diff
(100 %id)
R21739 placenta .d 1649 to 1855 208 to 1       208/290
(71 %)
4 diff
(98.7 %id)
AL697749 human skeletal muscle .d 1665 to 1852 1 to 188   AAA   188/188
(100 %)
1 diff
(99.5 %id)
EC560701 Prostate .d 1678 to 1778 5 to 103       99/103
(96 %)
6 diff
(94.2 %id)
FN098975 breast carcinoma .d 1692 to 1778 1 to 88       88/89
(98 %)
2 diff
(97.8 %id)
AI686988 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .d 1724 to 1852 149 to 21   AAA   129/129
(100 %)
0 diff
(100 %id)
DC357624   .e 1 to 545 1 to 545   tiling clone,   545/545
(100 %)
0 diff
(100 %id)
CF272401 Brain glioblastoma .e 4 to 563 1 to 564       564/823
(68 %)
21 diff
(97.5 %id)
BX507412 Liver .e 10 to 712 1 to 703       703/703
(100 %)
1 diff
(99.9 %id)
BP195446 brain .e 11 to 591 1 to 581       581/581
(100 %)
0 diff
(100 %id)
DC366450   .e 14 to 570 1 to 557       557/557
(100 %)
0 diff
(100 %id)
BP378653 uterus .e 16 to 566 1 to 551       551/554
(99 %)
16 diff
(97.2 %id)
DC297690   .e 17 to 580 1 to 564       564/564
(100 %)
1 diff
(99.9 %id)
DB157287 thymus .e 18 to 610 2 to 594   capped   593/593
(100 %)
0 diff
(100 %id)
DC303306 cerebellum .e 19 to 585 1 to 567       567/567
(100 %)
0 diff
(100 %id)
DB505394 hypothalamus .e 19 to 485 1 to 467       467/467
(100 %)
2 diff
(99.6 %id)
DC360740   .e 19 to 440 1 to 422       422/422
(100 %)
0 diff
(100 %id)
BP343833 stomach mucosa .e 19 to 603 1 to 585       585/585
(100 %)
1 diff
(99.9 %id)
DA043591 bladder .e 20 to 594 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DC425065   .e 27 to 582 1 to 556       556/556
(100 %)
0 diff
(100 %id)
CN346202 embryonic stem cells, DMSO-treated H9 cellline .e 29 to 599 7 to 577       571/577
(98 %)
6 diff
(99.0 %id)
BP262551 small intestine .e 45 to 613 1 to 570       570/570
(100 %)
8 diff
(98.6 %id)
DA920600 small intestine .e 53 to 617 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
CA396697 eye, RPE/choroid .e 55 to 502 13 to 460       448/460
(97 %)
10 diff
(97.9 %id)
DC394128 esophageal, tumor tissue .e 55 to 576 1 to 525       523/525
(99 %)
8 diff
(98.5 %id)
BF692715 melanotic melanoma, high MDR, skin .e 56 to 671 1 to 611       611/876
(69 %)
13 diff
(98.6 %id)
CN346199 embryonic stem cells, cell lines H1, H7, andH9 .e 63 to 352 1 to 292       292/292
(100 %)
3 diff
(99.0 %id)
DC425589   .e 65 to 420 1 to 356       356/356
(100 %)
1 diff
(99.8 %id)
AL697714 human skeletal muscle .e 67 to 655 1 to 589       589/589
(100 %)
0 diff
(100 %id)
BG777456 adenocarcinoma, Prostate .e 109 to 809 1 to 731       611/731
(83 %)
33 diff
(95.5 %id)
AU280205   .e 109 to 674 1 to 566       566/566
(100 %)
0 diff
(100 %id)
DA663163   .e 110 to 673 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
BJ990919 hepatoblastoma .e 148 to 727 1 to 580       580/580
(100 %)
1 diff
(99.9 %id)
EB388838 eye, optic nerve .e 155 to 924 1 to 770   tiling clone,   770/770
(100 %)
1 diff
(99.9 %id)
BQ899021 dorsal root ganglia .e 167 to 1002 1 to 849   tiling clone,   849/871
(97 %)
15 diff
(98.3 %id)
BJ990920 hepatoblastoma .e 1389 to 1928 540 to 1   tiling clone,   540/540
(100 %)
0 diff
(100 %id)
BG037144 testis .f 1 to 691 1 to 689   tiling clone,   689/1066
(64 %)
22 diff
(98.0 %id)
BI463599 testis .f 1 to 676 1 to 672   tiling clone,   672/672
(100 %)
11 diff
(98.4 %id)
BF980320 testis .f 1366 to 2070 709 to 6   tiling clone,   704/710
(99 %)
6 diff
(99.2 %id)
BI461511 testis .g 1 to 686 1 to 684   tiling clone,   684/695
(98 %)
12 diff
(98.3 %id)
BM924528 pooled colon, kidney, stomach .g 20 to 774 1 to 773       773/1136
(68 %)
22 diff
(98.1 %id)
DA831839 placenta .g 33 to 770 2 to 743   tiling clone, capped   742/744
(99 %)
11 diff
(98.6 %id)
BI463589 testis .g 47 to 778 1 to 732   tiling clone,   732/809
(90 %)
10 diff
(98.8 %id)
BG024942 lymph, lymphoma, cell line .g 61 to 768 1 to 707       707/1167
(60 %)
15 diff
(98.8 %id)
DB377706 placenta .g 1316 to 1888 570 to 1   tiling clone,   570/579
(98 %)
15 diff
(97.5 %id)
BX648022 human cervix .h 1 to 6155 1 to 6156 D185A tiling clone, available from DKFZ, AAA   6156/6156
(100 %)
4 diff
(100.0 %id)
H13090 placenta .h 3807 to 4263 1 to 468       468/470
(99 %)
25 diff
(94.7 %id)
BX538271 Liver .i 1 to 2201 1 to 2202 exact tiling clone, available from DKFZ, AAA   2202/2202
(100 %)
5 diff
(99.8 %id)
AK303940 trachea .j 1 to 1351 1 to 1351 exact tiling clone,   1351/1351
(100 %)
1 diff
(100.0 %id)
DC414634 trachea .j 1 to 499 1 to 500       500/500
(100 %)
1 diff
(99.8 %id)
BX647208 human endometrium .k 1 to 2087 1 to 2087 exact tiling clone, available from DKFZ, AAA   2087/2087
(100 %)
1 diff
(100.0 %id)
CN346197 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .k 14 to 459 1 to 446       446/446
(100 %)
3 diff
(99.4 %id)
DA757540   .k 161 to 730 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
BF238899 bone marrow, from chronic myelogenous leukemia .l 1 to 699 1 to 705 G24V G25E K26S C27A R28G ... tiling clone,   705/777
(90 %)
35 diff
(95.5 %id)
CD684138 normal nasopharynx .l 184 to 561 27 to 400   tiling clone,   374/400
(93 %)
7 diff
(98.3 %id)
DC386646   .m 1 to 571 1 to 570   tiling clone,   570/570
(100 %)
2 diff
(99.7 %id)
DC382820 Prostate .m 12 to 555 1 to 547       547/547
(100 %)
12 diff
(97.9 %id)
DB012130 esophageal, tumor tissue .m 449 to 1011 2 to 564   tiling clone, capped   563/563
(100 %)
0 diff
(100 %id)
DA135835 alzheimer cortex .m 761 to 1308 2 to 549   tiling clone, capped   548/548
(100 %)
0 diff
(100 %id)
BG499652 adenocarcinoma, Prostate .m 832 to 1428 1 to 597       597/597
(100 %)
5 diff
(99.2 %id)
BQ574740 Chondrosarcoma Grade II, Left Pelvis .m 986 to 1622 654 to 19   tiling clone, AAA   636/636
(100 %)
5 diff
(99.3 %id)
AA370149 Prostate .m 1031 to 1322 1 to 292   tiling clone,   292/292
(100 %)
0 diff
(100 %id)
CR597263 placenta .m 1486 to 2411 1 to 926   tiling clone,   926/926
(100 %)
0 diff
(100 %id)
AL541247 placenta .m 1486 to 2447 1 to 963       963/963
(100 %)
1 diff
(99.9 %id)
BQ015030 Chondrosarcoma, Left Pubic Bone .m 1721 to 2376 674 to 19   AAA   656/656
(100 %)
1 diff
(99.9 %id)
BM793417 stomach .m 1823 to 2443 1 to 620       620/620
(100 %)
1 diff
(99.9 %id)
BM785985 Ascites, stomach .m 1848 to 2444 1 to 597       597/597
(100 %)
2 diff
(99.7 %id)
AI703480 carcinoid, lung .m 1895 to 2444 550 to 1       550/550
(100 %)
3 diff
(99.5 %id)
BE220680 carcinoid, lung .m 1898 to 2444 547 to 1   tiling clone,   547/547
(100 %)
0 diff
(100 %id)
BP395677 pancreatic islet .m 1956 to 2431 1 to 478     Submitted on the opposite strand 478/478
(100 %)
2 diff
(99.6 %id)
AI262759 Kidney .m 1956 to 2445 488 to 1       488/488
(100 %)
5 diff
(99.0 %id)
AI280721 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .m 1972 to 2444 473 to 1       473/473
(100 %)
3 diff
(99.4 %id)
AI038099 parathyroid gland, parathyroid tumor .m 1997 to 2447 457 to 7       451/457
(98 %)
0 diff
(100 %id)
AI052040 parathyroid gland, parathyroid tumor .m 2016 to 2444 443 to 15   AAA   429/429
(100 %)
1 diff
(99.8 %id)
AI299914 carcinoid, lung .m 2020 to 2444 425 to 1       425/425
(100 %)
0 diff
(100 %id)
AI031922 parathyroid gland, parathyroid tumor .m 2021 to 2444 434 to 11   AAA   424/424
(100 %)
2 diff
(99.6 %id)
N91539 lung .n 1 to 588 1 to 584 N118M V119F Y120T S121A N123I ... tiling clone, Submitted on the opposite strand 584/584
(100 %)
13 diff
(97.8 %id)
BQ367524 placenta_normal .n 31 to 608 618 to 43 A41G N43E P44S V45S R46S ...     576/618
(93 %)
21 diff
(96.7 %id)
CA413039 Chondrosarcoma Grade II, Left Pelvis .n 44 to 784 758 to 19 exact tiling clone, AAA   740/740
(100 %)
2 diff
(99.8 %id)
BE906111 epithelioid carcinoma, Pancreas .n 54 to 745 1 to 684 L13C Y14I S15R Y16I S17Q ...     684/901
(75 %)
19 diff
(97.9 %id)
CF126723 Chondrosarcoma Lung Metastasis cell lines, lung .n 81 to 727 1 to 647 exact     647/647
(100 %)
5 diff
(99.3 %id)
TI_154189764   .n 81 to 831 57 to 807 exact tiling clone,   751/1045
(71 %)
23 diff
(97.8 %id)
TI_149307560   .n 86 to 793 825 to 118 exact tiling clone, AAA   708/972
(72 %)
2 diff
(99.8 %id)
AK309222 thalamus .o 1 to 1160 3 to 1171 exact tiling clone,   1171/1171
(100 %)
9 diff
(99.3 %id)
DC343049 thalamus .o 1 to 550 3 to 561 exact     561/561
(100 %)
7 diff
(98.8 %id)
DC321799 brain .p 1 to 567 1 to 567   tiling clone,   567/567
(100 %)
0 diff
(100 %id)
DC377730 brain .p 7 to 575 1 to 569       569/569
(100 %)
0 diff
(100 %id)
DC307801 cerebellum .p 15 to 582 1 to 571       571/571
(100 %)
5 diff
(99.2 %id)
AK304250 trachea .p 42 to 1483 1 to 1442 exact tiling clone,   1442/1442
(100 %)
2 diff
(99.9 %id)
DC417349 trachea .p 42 to 591 1 to 550       550/550
(100 %)
0 diff
(100 %id)
DC308271 cerebellum .p 105 to 659 1 to 556 D2T     556/556
(100 %)
3 diff
(99.5 %id)
BQ003666 Chondrosarcoma, Left Pelvis .p 307 to 926 646 to 19   AAA   628/628
(100 %)
8 diff
(98.8 %id)
AA935887 pooled .p 536 to 929 394 to 1   tiling clone,   394/394
(100 %)
2 diff
(99.5 %id)
AA829995 germinal center B cell .p 624 to 871 248 to 1       248/248
(100 %)
0 diff
(100 %id)
DA320815 hippocampus .p 727 to 1290 2 to 565   tiling clone, capped   564/565
(99 %)
7 diff
(98.8 %id)
DA320816 hippocampus .p 727 to 1277 2 to 551   capped   550/550
(100 %)
6 diff
(99.0 %id)
DA321885 hippocampus .q-u 1 to 557 2 to 558 exact tiling clone, capped   557/557
(100 %)
2 diff
(99.7 %id)
BG502784 embryonal carcinoma, testis .q-u 25 to 697 1 to 671 E84R E85S H86I L87C F88S ...     671/671
(100 %)
2 diff
(99.8 %id)
CN346198 embryonic stem cells, DMSO-treated H9 cellline .q-u 37 to 791 3 to 758 E73*     756/758
(99 %)
6 diff
(99.3 %id)
AW630465 2 pooled high-grade transitional celltumors, genitourinary tract .q-u 53 to 396 1 to 352       352/352
(100 %)
10 diff
(97.2 %id)
BG393925 embryonal carcinoma, cell line, testis .q-u 122 to 1041 1 to 916 P12R S13H F15S R16G V17* tiling clone,   916/941
(97 %)
28 diff
(97.1 %id)
BY795784 eye .q-u 123 to 768 1 to 646 exact     646/646
(100 %)
0 diff
(100 %id)
CN346201 embryonic stem cells, cell lines H1, H7, andH9 .q-u 146 to 723 1 to 578       578/578
(100 %)
4 diff
(99.4 %id)
AA491183 germinal center B cell .q-u 175 to 539 1 to 364       364/364
(100 %)
2 diff
(99.5 %id)
AW971488   .q-u 341 to 983 644 to 1   tiling clone, Submitted on the opposite strand 644/644
(100 %)
3 diff
(99.6 %id)
AI910858 pooled .q-u 442 to 984 543 to 1       543/543
(100 %)
1 diff
(99.9 %id)
BE815919 breast_normal .q-u 455 to 690 1 to 241       241/241
(100 %)
12 diff
(95.1 %id)
BE815910 breast_normal .q-u 456 to 682 228 to 1       228/243
(93 %)
18 diff
(92.6 %id)
AA490987 germinal center B cell .q-u 570 to 984 425 to 10       416/425
(97 %)
0 diff
(100 %id)
AA905855 pooled .q-u 585 to 988 404 to 1       404/404
(100 %)
0 diff
(100 %id)
BG284760 adenocarcinoma, cell line, Prostate .q-u 804 to 1420 1 to 619   tiling clone,   619/619
(100 %)
14 diff
(97.8 %id)
AA913717 pooled .q-u 912 to 989 78 to 1   tiling clone,   78/78
(100 %)
0 diff
(100 %id)
TI_149272187   .q-u 1255 to 2051 883 to 88   tiling clone, AAA   796/985
(80 %)
29 diff
(97.1 %id)
BU674901 lung, Primary Lung Epithelial Cells .q-u 1438 to 2051 632 to 19   tiling clone, AAA   614/614
(100 %)
1 diff
(99.9 %id)
AW627445 2 pooled high-grade transitional celltumors, genitourinary tract .q-u 1897 to 2054 163 to 5       159/163
(97 %)
0 diff
(100 %id)
BX495943 Liver .r 1 to 630 1 to 630 G4W V6C Y7I I8H L9F ... tiling clone,   630/630
(100 %)
4 diff
(99.4 %id)
AA399961   .r 518 to 1056 1 to 539   tiling clone,   539/539
(100 %)
0 diff
(100 %id)
AA128347 uterus .r 849 to 1339 1 to 495   tiling clone,   495/495
(100 %)
5 diff
(99.0 %id)
TI_149297300   .r 1254 to 2098 939 to 111   tiling clone, AAA   829/905
(91 %)
19 diff
(98.0 %id)
BM982391 lung, Primary Lung Cystic Fibrosis EpithelialCells .r 1412 to 2098 705 to 19   tiling clone, AAA   687/687
(100 %)
12 diff
(98.3 %id)
AA085746 uterus .r 1541 to 2102 561 to 1       561/562
(99 %)
3 diff
(99.5 %id)
AA401305   .r 1572 to 2104 535 to 3   tiling clone,   533/535
(99 %)
0 diff
(100 %id)
DC317026 amygdala .s 1 to 544 1 to 545 L45P R46P L47S A48S Q49S ... tiling clone,   545/545
(100 %)
2 diff
(99.7 %id)
BX118248 pooled .s 29 to 623 1 to 595   tiling clone,   595/595
(100 %)
5 diff
(99.2 %id)
BX641086 human endometrium carcinoma cell line .t 1 to 7352 1 to 7354 exact tiling clone, available from DKFZ, AAA   7354/7354
(100 %)
27 diff
(99.7 %id)
DA538864 Kidney .t 17 to 599 2 to 587   capped   586/586
(100 %)
3 diff
(99.5 %id)
DA016991 adrenal gland .t 19 to 549 2 to 533   capped   532/532
(100 %)
1 diff
(99.9 %id)
DA537123 heart .t 19 to 574 2 to 558   capped   557/557
(100 %)
5 diff
(99.2 %id)
DA468660   .t 21 to 569 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DA965719 stomach .t 21 to 568 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
DA982564 synovial membrane tissue from rheumatioidarthritis .t 27 to 582 2 to 559   capped   558/558
(100 %)
2 diff
(99.7 %id)
DA431729 colon .t 29 to 592 13 to 577   capped   565/576
(98 %)
6 diff
(99.0 %id)
DA600542   .t 30 to 601 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
BX503961   .t 46 to 586 1 to 541       541/541
(100 %)
1 diff
(99.9 %id)
BP328284 rectum .t 55 to 634 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
DB212666 trachea .t 56 to 536 2 to 482   capped   481/481
(100 %)
0 diff
(100 %id)
DB264806 uterus .t 56 to 474 2 to 420   capped   419/419
(100 %)
0 diff
(100 %id)
DA747716   .t 981 to 1545 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
BX472355   .t 1159 to 1907 1 to 749   tiling clone,   749/749
(100 %)
4 diff
(99.5 %id)
BG005179 placenta_normal .t 1288 to 1722 444 to 9       436/444
(98 %)
0 diff
(100 %id)
AW860760 colon .t 1644 to 2087 476 to 33   tiling clone,   444/476
(93 %)
0 diff
(100 %id)
DB518812 testis .t 3454 to 3914 1 to 462   tiling clone, Submitted on the opposite strand 462/462
(100 %)
1 diff
(99.8 %id)
BF852778 lung_normal .t 3645 to 4122 592 to 113     Submitted on the opposite strand 480/592
(81 %)
0 diff
(100 %id)
T94676 lung .t 4365 to 4662 1 to 306   tiling clone,   306/344
(88 %)
15 diff
(95.7 %id)
BX646574   .t 4556 to 5066 1 to 510       510/510
(100 %)
6 diff
(98.9 %id)
FN093373 breast carcinoma .t 4694 to 4791 96 to 1     Submitted on the opposite strand 96/96
(100 %)
2 diff
(98.0 %id)
AI912337 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .t 5150 to 5651 502 to 1   tiling clone,   502/502
(100 %)
0 diff
(100 %id)
CN304222 embryonic stem cells, DMSO-treated H9 cellline .t 5172 to 5411 1 to 240       240/240
(100 %)
2 diff
(99.2 %id)
BX119747 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .t 5199 to 5663 465 to 1   tiling clone, Submitted on the opposite strand 465/465
(100 %)
0 diff
(100 %id)
T94324 lung .t 5225 to 5581 370 to 1       370/375
(98 %)
18 diff
(95.2 %id)
AW975972   .t 5261 to 5649 110 to 498   AAA   389/498
(78 %)
9 diff
(98.2 %id)
AA747082 alveolar rhabdomyosarcoma .t 5270 to 5664 1 to 395       395/401
(98 %)
3 diff
(99.3 %id)
R39715 placenta .u 1 to 335 1 to 342   tiling clone,   342/349
(97 %)
11 diff
(96.9 %id)
AW665902 pooled .u 183 to 745 567 to 1   tiling clone,   567/567
(100 %)
2 diff
(99.7 %id)
H04554 placenta .u 321 to 838 1 to 514   tiling clone,   514/550
(93 %)
29 diff
(94.8 %id)
FN051717 breast carcinoma .u 434 to 545 112 to 1     Submitted on the opposite strand 112/113
(99 %)
1 diff
(99.2 %id)
BU854220 testis .u 821 to 1566 1 to 746 exact tiling clone,   746/747
(99 %)
7 diff
(99.1 %id)
TI_154048216   .u 1092 to 1944 936 to 93 F10X tiling clone, AAA   844/995
(84 %)
15 diff
(98.5 %id)
DA812686 ovary, tumor tissue .va-u 1 to 536 2 to 541   tiling clone, capped   540/548
(98 %)
10 diff
(98.2 %id)
CN346200 embryonic stem cells, cell lines H1, H7, andH9 .va-u 969 to 1652 1 to 693 exact tiling clone,   693/693
(100 %)
8 diff
(98.9 %id)
DB372141 ovary, tumor tissue .va-u 1274 to 1803 545 to 1   tiling clone,   545/545
(100 %)
15 diff
(97.3 %id)
AI445195 colon, moderately-differentiated adenocarcinoma .vb-u 1 to 418 418 to 1   tiling clone,   418/418
(100 %)
1 diff
(99.8 %id)
BG434175 placenta .vb-u 298 to 1050 1 to 758   tiling clone,   758/761
(99 %)
11 diff
(98.6 %id)
TI_154117511   .vb-u 507 to 1377 945 to 81 exact AAA   865/926
(93 %)
21 diff
(97.8 %id)
BQ014977 Chondrosarcoma, Left Pubic Bone .vb-u 699 to 1392 711 to 19 exact tiling clone, AAA   693/693
(100 %)
1 diff
(99.9 %id)
CA449678 Chondrosarcoma, Left Pelvis .vb-u 730 to 1377 666 to 19 exact AAA   648/648
(100 %)
0 diff
(100 %id)
AA033665 uterus .vb-u 817 to 985 1 to 169       169/169
(100 %)
0 diff
(100 %id)
AW614529 Kidney .vb-u 846 to 1384 539 to 1 exact     539/539
(100 %)
0 diff
(100 %id)
AI242393 follicular lymphoma, lymph node .vb-u 951 to 1384 434 to 1 exact     434/435
(99 %)
0 diff
(100 %id)
AA032210 uterus .vb-u 985 to 1351 369 to 1 exact     369/369
(100 %)
2 diff
(99.5 %id)
BG724228 testis .vc 1 to 586 1 to 585   tiling clone,   585/585
(100 %)
6 diff
(99.0 %id)
CF141458 CNCAP(3)T-225 cell line, Prostate .vc 425 to 921 1 to 497   tiling clone,   497/497
(100 %)
6 diff
(98.8 %id)
TI_154172243   .vc 432 to 1040 80 to 688   tiling clone,   609/609
(100 %)
7 diff
(98.9 %id)
DA131589 alzheimer cortex .vd 1 to 633 2 to 634 exact tiling clone, capped   633/633
(100 %)
0 diff
(100 %id)
DC367658   .ve 1 to 580 1 to 581 exact tiling clone,   581/581
(100 %)
2 diff
(99.7 %id)
DA172475 amygdala .vf-u 1 to 575 2 to 576 exact tiling clone, capped   575/575
(100 %)
1 diff
(99.9 %id)
BE697435 colon .vf-u 145 to 572 1 to 423 Y2F L3S L4T Q5D P6V ...     423/423
(100 %)
23 diff
(94.6 %id)
BQ317927 colon .vf-u 146 to 569 1 to 424 Y2L L3V L4T Q5T P6D ...     424/424
(100 %)
22 diff
(94.9 %id)
BE697434 colon .vf-u 147 to 537 1 to 392 Q5P P6H I7R V8S N9*     392/392
(100 %)
14 diff
(96.5 %id)
BE697440 colon .vf-u 148 to 556 1 to 406 Y2L L3Y L4Q Q5P P6M ...     406/406
(100 %)
22 diff
(94.6 %id)
BE697442 colon .vf-u 148 to 549 1 to 395 Y2F L3Y L4T Q5D P6C ...     395/395
(100 %)
6 diff
(98.5 %id)
DA127205 cerebellum .vg-u 1 to 574 2 to 576 A21C L22F I23D I24Y tiling clone, capped   575/575
(100 %)
1 diff
(99.9 %id)
DA231877 brain .vh-u 1 to 555 2 to 559 exact tiling clone, capped   558/558
(100 %)
1 diff
(99.9 %id)
DB032631 testis .vi 1 to 548 2 to 549 exact tiling clone, capped   548/548
(100 %)
0 diff
(100 %id)
DB073356 testis .vj 1 to 527 2 to 528 exact tiling clone, capped   527/527
(100 %)
2 diff
(99.7 %id)
AI905404 breast Gene SLC35B3, variant not shown              
DB306517 caudate nucleus Gene SLC35B3, variant not shown              
DA255851 caudate nucleus Gene SLC35B3, variant not shown       capped      
AV729071 hypothalamus Gene SLC35B3, variant not shown         This clone was ignored    
AV728994 hypothalamus Gene SLC35B3, variant not shown         Suspected internal deletion, this clone was ignored    
BF242937 bone marrow, from acute myelogenous leukemia Gene SLC35B3, variant not shown         Suspected internal deletion, this clone was ignored    
BG776219 lung, mucoepidermoid carcinoma Gene SLC35B3, variant not shown         Suspected internal deletion, this clone was ignored    
BU737149 eye, fetal eyes Gene SLC35B3, variant not shown       AAA Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q-u, .r, .s, .t, .u, .va-u, .vb-u, .vc, .vd, .ve, .vf-u, .vg-u, .vh-u, .vi, .vj Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C